(NASDAQ:KRYS), PITTSBURGH, Jan. 07, 2026 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that it will host an investor conference call and webcast tomorrow, Thursday, January 8, 2026, at 4:30 pm ET, to disclose an interim clinical update from CORAL-1, the Company's multi-center, dose escalation Phase 1 study evaluating KB407 in […]

(NasdaqGM:FLY), SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Firefly Aerospace Inc. (NASDAQ: FLY): (i) securities between August 7, 2025 and September 29, 2025, inclusive (the “Class Period”); and/or (ii) common stock pursuant and/or traceable to Firefly Aerospace's offering documents issued in connection

(NYSE:CXT), WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) — Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, announced that Aaron Saak, President and Chief Executive Officer, and Christina Cristiano, Senior Vice President and Chief Financial Officer, will participate in a fireside chat at the CJS Securities 26th Annual New Ideas for the New

(NYSE:ETD), DANBURY, CT, Jan. 07, 2026 (GLOBE NEWSWIRE) — Ethan Allen Interiors Inc. (“Ethan Allen” or the “Company”) (NYSE: ETD) will release its financial and operational results for the fiscal 2026 second quarter ended December 31, 2025, after the stock market closes on Wednesday, January 28, 2026. Following the release, the Company will host a

(Paris:ABVX),(NasdaqGM:ABVX), Abivax Provides 2026 Corporate Outlook New market insights indicate significant future expansion of the ulcerative colitis (UC) market, with obefazimod well positioned to become a future market leader in the IBD space ABTECT Phase 3 Data Safety Monitoring Board (DSMB) meeting on December 18, 2025, found no new safety signals with over 80% of

Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire January 07, 2026 FLORHAM PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that it intends to offer and sell, subject to

Saratoga Investment Corp. Announces Fiscal Third Quarter 2026 Financial Results GlobeNewswire January 07, 2026 Reports 5.2% Increase in NII Per Share and 0.7% Increase in NAV from Previous Quarter, with NAV Per Share Remaining Stable Quarterly ROE of 13.5% Generates LTM ROE of 9.7% and Beats the BDC Industry Average of 6.6% NEW YORK, Jan.

Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love,

LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation GlobeNewswire January 07, 2026 SALT LAKE CITY, Jan. 07, 2026 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the addition of

Kura Sushi USA Announces Fiscal First Quarter 2026 Financial Results Company to host fireside chat and investor meetings at the 28th Annual ICR Conference GlobeNewswire January 07, 2026 IRVINE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”) (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced financial